Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2017 1
2018 4
2019 1
2020 2
2021 2
2022 1
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn's disease in Europe: a retrospective observational study.
Weisshof R, Vavricka SR, Pouillon L, Braegger F, Roset M, Bent-Ennakhil N, Ferrante M. Weisshof R, et al. Among authors: bent ennakhil n. BMC Gastroenterol. 2023 Nov 29;23(1):417. doi: 10.1186/s12876-023-03032-7. BMC Gastroenterol. 2023. PMID: 38030966 Free PMC article.
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom.
Assaf C, Illidge TM, Waser N, He M, Li T, Zomas A, Bent-Ennakhil N, Little M, Ortiz-Romero PL, Pimpinelli N, Dalal M, Bagot M. Assaf C, et al. Among authors: bent ennakhil n. Cancers (Basel). 2023 Nov 30;15(23):5669. doi: 10.3390/cancers15235669. Cancers (Basel). 2023. PMID: 38067371 Free PMC article.
Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting.
Ludwig H, Ramasamy K, Mateos MV, Kishore B, Gergely V, Ladicka M, Ori A, Simoni L, Bent-Ennakhil N, Stull DM, Gavini F, Terpos E, Hájek R. Ludwig H, et al. Among authors: bent ennakhil n. Clin Lymphoma Myeloma Leuk. 2024 Feb;24(2):e40-e49.e3. doi: 10.1016/j.clml.2023.10.003. Epub 2023 Oct 14. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37996265 Free article.
Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.
Plattel WJ, Bergamasco A, Trinchese F, Gavini F, Bent-Ennakhil N, Zomas A, Castillon G, Arredondo-Bisono T, Cristarella T, Moride Y, von Tresckow B. Plattel WJ, et al. Among authors: bent ennakhil n. Leuk Lymphoma. 2021 Dec;62(14):3320-3332. doi: 10.1080/10428194.2021.1957865. Epub 2021 Jul 29. Leuk Lymphoma. 2021. PMID: 34323643
18 results